Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 17 Jun 2026 for Aprea Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleJean-Pierre Bizzari
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
Jean-Pierre Bizzari: trading record in brief
This profile gathers the share dealings of Jean-Pierre Bizzari across 3 companies, led by ADC Therapeutics SA, Halozyme Therapeutics, Inc. and Aprea Therapeutics, Inc. The record holds 12 filings, for trades running from 5 May 2021 to 16 June 2026.
Every open-market trade on record is a sale: 2 sales worth €1.2M. Besides market trades, the filings include 10 share grants.
The latest filing, published on 17 June 2026, reports a share grant in Aprea Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jean-Pierre Bizzari
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
3,135 sharesCommon StockSEC:0001104659-26-075281:0
45,000 shares0Common SharesSEC:0001628280-26-040488:0
12,600 shares@ US$3.0836.7% of flowCommon SharesSEC:0001628280-26-040488:1
12,600 shares@ US$3.5842.7% of flowCommon SharesSEC:0001628280-25-031891:0
1,045 shares0Common StockSEC:0001104659-25-057806:0
40,000 shares0Common SharesSEC:0001628280-25-029735:0
▼
Same trade as the filing by Robert Azelby, counted once · View ↗
6,995 shares@ US$2.8920.7% of flowCommon SharesSEC:0001628280-24-028992:0
40,000 shares0Common SharesSEC:0001628280-24-028355:0
8,065 shares0Common StockSEC:0001415889-23-007687:0
6,206 shares0Restricted Stock UnitsSEC:0001179110-22-002906:0
35,000 shares@ US$41.013100.0% of flowCommon StockSEC:0001179110-21-008418:0
5,230 shares0Restricted Stock UnitsSEC:0001179110-21-004969:0
12 of 11 declarations
